Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia. - Test2 - elhamkhani - TriplyDB

Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia.

Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia.

http://www.wikidata.org/entity/Q48604379

about

Nanoscale drug delivery systems and the blood-brain barrier Role of Nogo-A in neuronal survival in the reperfused ischemic brain Spatiotemporal Changes in P-glycoprotein Levels in Brain and Peripheral Tissues Following Ischemic Stroke in Rats Rapid, reversible modulation of blood-brain barrier P-glycoprotein transport activity by vascular endothelial growth factor.Translational pharmacokinetics: challenges of an emerging approach to drug development in stroke.Functional Expression of P-glycoprotein and Organic Anion Transporting Polypeptides at the Blood-Brain Barrier: Understanding Transport Mechanisms for Improved CNS Drug Delivery?Influence of ATP-binding cassette polymorphisms on neurological outcome after traumatic brain injury.Interactions between antidepressants and P-glycoprotein at the blood-brain barrier: clinical significance of in vitro and in vivo findings.Effects of normobaric oxygen and melatonin on reperfusion injury: role of cerebral microcirculation ABCB1 genotype and CSF beta-amyloid in Alzheimer disease Identification of P-glycoprotein co-fractionating proteins and specific binding partners in rat brain microvessels.Improved Antidepressant Remission in Major Depression via a Pharmacokinetic Pathway Polygene Pharmacogenetic Report.ATP-binding cassette transporters in immortalised human brain microvascular endothelial cells in normal and hypoxic conditions Association between ABCB1 Polymorphisms and Ischemic Stroke in Korean Population The dual cyclooxygenase/5-lipoxygenase inhibitor licofelone attenuates p-glycoprotein-mediated drug resistance in the injured spinal cord.The failure of animal models of neuroprotection in acute ischemic stroke to translate to clinical efficacy.Interaction of HM30181 with P-glycoprotein at the murine blood-brain barrier assessed with positron emission tomography Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy.ATP-binding cassette transporters and their roles in protecting the brain.Neurological diseases in relation to the blood-brain barrier.Blood-brain barrier pathophysiology in traumatic brain injury.The abluminal endothelial membrane in neurovascular remodeling in health and disease.Neurovascular remodeling in the aged ischemic brain.Importance of ABCC1 for cancer therapy and prognosis.P-glycoprotein trafficking as a therapeutic target to optimize CNS drug delivery.ABC transporters at the blood-brain barrier.Transporters as Drug Targets in Neurological Diseases The pivotal role of astrocytes in an in vitro stroke model of the blood-brain barrier.The ATP-binding cassette transporters ABCB1 and ABCC1 are not regulated by hypoxia in immortalised human brain microvascular endothelial cells.CJY, an isoflavone, interacts with ATPase of P-glycoprotein in the rat brain microvessel endothelial cells (RBMECs).Nitric oxide contributes to hypoxia-reoxygenation-induced P-glycoprotein expression in rat brain endothelial cells.Future Perspectives for Brain Pharmacotherapies: Implications of Drug Transport Processes at the Blood-brain Barrier.P-glycoprotein (ABCB1) and Oxidative Stress: Focus on Alzheimer's Disease.Rifampicin attenuates experimental autoimmune encephalomyelitis by inhibiting pathogenic Th17 cells responses.Liver X receptor activation enhances blood-brain barrier integrity in the ischemic brain and increases the abundance of ATP-binding cassette transporters ABCB1 and ABCC1 on brain capillary cells.Modulation of P-glycoprotein in rat brain microvessel endothelial cells under oxygen glucose deprivation.Time-of-Day Dependent Neuronal Injury After Ischemic Stroke: Implication of Circadian Clock Transcriptional Factor Bmal1 and Survival Kinase AKT.Lysophosphatidic acid and amitriptyline signal through LPA1R to reduce P-glycoprotein transport at the blood-brain barrier.Alteration in P-glycoprotein at the blood-brain barrier in the early period of MCAO in rats.Neuroimmune Axes of the Blood-Brain Barriers and Blood-Brain Interfaces: Bases for Physiological Regulation, Disease States, and Pharmacological Interventions.

P2860

Q27026978-1ACF559A-F76C-4F1A-AAE8-60CAD053E43C Q33525257-CF5572E1-2536-4EDF-9123-63F103F10930 Q33583533-5A396328-B989-48C1-834B-728A4A599769 Q33697616-77C0C9A7-DA71-42B8-AAD1-0B87D3A90672 Q33882182-A9D4050E-51E1-4691-AF32-5C5B4292D623 Q33893813-4C7704B4-BD0A-42C0-8545-6C04AA93C4A5 Q35095391-045C63E5-DC79-4D7D-AF74-360C9F94CF87 Q35708089-F4901BC1-8C6E-4BA1-B88B-F07036079449 Q35791055-67E20E54-6366-4864-A5B1-495E8A6DFB99 Q35801727-5C3C1373-430F-4C4F-B2AB-E669B4020DED Q35815787-8A472405-6312-4BED-8A1C-C1845BE4D25D Q35965584-12C5D601-F91A-413D-B087-903B3D12A4EE Q36303213-9C2B5D5C-6704-4E15-8713-20D506BDD918 Q36512040-7946BCC3-3471-4B87-8606-348F4D3D6E72 Q36590671-88D961C6-D924-4DC1-9171-61674C7A192E Q36802095-3728375C-0EB1-4BF0-B0B1-D640BC81C07A Q36949407-269D9C05-348C-4C67-9A16-4A45C0356CC2 Q37080236-0BC2ADBD-028B-4998-A54C-C3CA9EE45D08 Q37868835-EB118398-C3B2-46A3-A6F2-7933867999B8 Q37976564-8ABC92CC-7FBE-43D4-AEDA-E18733F464A9 Q37980746-6BC60D3E-A29B-4AD9-B8B4-A59AEC01605B Q38032676-478519E3-DE6B-4FB8-8278-1D3A456B5FF0 Q38174779-54C732D3-18B0-4BC2-9686-736AC4C5FABA Q38199535-AA11E82A-9C13-4146-AA2E-C318B17FA006 Q38259301-F90BF459-2B88-4739-B6CE-A0755BBF56B9 Q38783122-CBCC3F9E-4494-49E1-9A00-C9CA282D823D Q38905608-1D8E3407-13F5-47D0-A668-589C87EE68C0 Q38941062-F966D7F8-A43B-4EA8-83A1-CDFFE9DDBCB4 Q39023684-19508963-05A4-493B-A7BF-386364B49ED8 Q39088427-EF53CCEC-FC51-4F32-8291-9203634B005B Q39535296-BB8A80EF-EE8D-4466-8BB8-E16A6E4FB620 Q40031757-0E691388-6AA8-4A24-983C-2B83EB82803C Q47873232-5C1A2B99-F5C4-465C-9A9E-CE27F079D7D2 Q47970743-DE94FD73-239B-4C62-898C-DA7BB630A62A Q49036874-62627597-5E76-4BF9-9CA8-BF5D67A32850 Q49041875-E3489B44-6799-4BC5-BC2D-24D9DE361BB0 Q50718011-BBC25E14-DA09-4BDC-94F5-D708F135712C Q51032610-A2C1FF13-E506-45A2-A5C4-AAA09611844B Q51060989-C799207A-89CF-4256-898E-D530FD63C889 Q52689036-643C1E9F-0BF5-424A-9454-5DAAC02AE6C2

P2860

Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia.

http://www.wikidata.org/entity/Q48604379

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Inhibition of multidrug resist ...... after focal cerebral ischemia.

@en

Inhibition of multidrug resist ...... after focal cerebral ischemia.

@nl

type

label

Inhibition of multidrug resist ...... after focal cerebral ischemia.

@en

Inhibition of multidrug resist ...... after focal cerebral ischemia.

@nl

prefLabel

Inhibition of multidrug resist ...... after focal cerebral ischemia.

@en

Inhibition of multidrug resist ...... after focal cerebral ischemia.

@nl

P1433

Q48604379-4E27CE30-EF92-47E9-A16A-35D0B7E833EF

P1476

Q48604379-AA9DBA3C-D0A4-430A-A304-DC1BD14F4956

P2093

Q48604379-339526D4-7B99-42D0-BEDA-E326CC0C5734

Q48604379-5A95363C-CBB0-4E84-A652-1933651EB1B7

Q48604379-831A33B6-0100-4F7B-BFCF-5F96F9D4755C

Q48604379-8683CBAC-6B37-4D6A-B104-81CB7BC0847F

Q48604379-9A798C3E-B399-4025-84CB-953DCF3CBC9E

Q48604379-B4CF36BD-CC40-4C37-A9CA-04AE1FD728C4

Q48604379-DAA24FB5-D1AE-498E-8E29-EF5743A65FCD

Q48604379-E05C33DB-1FDD-44CA-B742-4C06F7E5039C

P2860

Q48604379-1D1421A5-25AD-4226-BC58-7937D37CAA38

Q48604379-52E4967D-31C5-46F7-9025-AA20F0B1E2C3

Q48604379-961D296E-5D6E-4A82-90D9-BA62AE5F37E5

Q48604379-9FD17136-2D4A-447E-B477-84FA1D34462B

Q48604379-B8CB7A9E-E268-493D-B11F-35323C44B094

Q48604379-C3829438-A341-4801-B09A-42413BC7FA48

Q48604379-C62F40E1-3FB8-4D5D-9C4F-B9B60401C088

P2888

Q48604379-DD048021-DEBD-4ACA-B5C5-6AB4EE25C428

P304

Q48604379-447A618C-9694-4F5B-AC9B-A6F3529113F2

P31

Q48604379-37B38B7E-9BF7-4D19-9EED-9EBBEDFBB54F

P356

Q48604379-308C13EB-755B-4E60-A5BB-252436ABAD3E

P407

Q48604379-D938B068-E337-4F22-9537-0B70DE8EACB3

P433

Q48604379-B54598D6-3E81-4238-AB6C-DD3B59DBEA8B

P478

Q48604379-43E258F8-8CAC-4533-8904-7F7DDA8B9DFD

P577

Q48604379-603ACD25-B378-4813-9F5C-114FFC6F726E

P5875

Q48604379-C923B4FC-74B4-43B2-8DCA-1B2B4721D185

P6179

Q48604379-3B098EAE-F3AA-4D18-84C6-585A5952DBEE

P698

Q48604379-3E3D1C6E-60C2-4467-AE61-181461D84153

P921

Q48604379-1BD011DC-16E6-4BD6-AD50-44519C93F90A

Q48604379-45B66785-D87B-4D74-AA1A-1C0C5E105E2F

P356

P1433

Nature Neuroscience

P1476

Inhibition of multidrug resist ...... after focal cerebral ischemia.

@en

P2093

Annett Spudich

http://www.w3.org/2001/XMLSchema#string

Claudio L Bassetti

http://www.w3.org/2001/XMLSchema#string

Dirk M Hermann

http://www.w3.org/2001/XMLSchema#string

Ertugrul Kilic

http://www.w3.org/2001/XMLSchema#string

Heidi Wunderli-Allenspach

http://www.w3.org/2001/XMLSchema#string

Hongyi Xing

http://www.w3.org/2001/XMLSchema#string

Katharina M Rentsch

http://www.w3.org/2001/XMLSchema#string

Ulkan Kilic

http://www.w3.org/2001/XMLSchema#string

P2860

The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux

Multidrug resistance in cancer: role of ATP-dependent transporters

Rifampicin attenuates brain damage in focal ischemia.

Drug resistance in brain diseases and the role of drug efflux transporters.

Role of multidrug transporters in pharmacoresistance to antiepileptic drugs.

Multidrug-resistance protein 1 in focal cortical dysplasia.

Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia

P2888

P304

487-488

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NN1676

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2006-03-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7213005

http://www.w3.org/2001/XMLSchema#string

P6179

1040630723

http://www.w3.org/2001/XMLSchema#string

P698

16565717

http://www.w3.org/2001/XMLSchema#string

P921

cerebral infarction

multiple drug resistance